Recommended

27

Scott Gallacher: The painful truth about insistent clients

One of the many unintended consequences of the new pension freedoms is that, while technically people can cash in their pensions, the reality is most providers are unwilling to carry the can should things go wrong. This is most problematic with defined benefits schemes, where the existing scheme will not facilitate encashment. Instead, members must […]

SimplyBiz ditches sale and IPO plans

Support services and compliance firm SimplyBiz has shelved plans to sell the business or launch an IPO and is instead exploring alternative funding options to remain independent. In January, SimplyBiz confirmed it was considering floating the business on the Alternative Investment Market or selling a stake in the firm to a trade buyer or private […]

Nigel Farage Ukip leader 2013 700 x 450.jpg

Nigel Farage and Nick Clegg quit after election drubbing

Nigel Farage will stand down as leader of Ukip after losing out in his bid to be elected as the MP for Thanet South. Liberal Democrat leader Nick Clegg has also confirmed he will quit as leader after a “crushing” election night. Labour leader Ed Miliband will also exit following a shattering result for the […]

Older-Couple-Elderly-Pension-Pensioner-700.jpg
6

Think-tank: UK market still well suited to annuities despite pension freedoms

Despite the pension reforms the UK market remains well suited to annuitisation, influential think-tank the Pensions Policy Institute says. In a report, sponsored by the Investment Association and The People’s Pension, the PPI compares the UK system with Australia, Ireland, New Zealand and the US. It says that despite the new freedoms – which allow […]

State of the markets: UK equity income

Artemis Income Fund manager Nick Shenton discusses the state of the UK equity income market with journalist Alexis Xydias. With the first three months of 2015 showing strong returns for both the Artemis Income Fund and UK markets generally, Nick Shenton discusses the fund’s top contributors – including overseas holdings Novartis and Bayer – and […]

Newsletter

News and expert analysis straight to your inbox

Sign up

Comments

    Leave a comment